Ek B
Department of Pharmacology and Biochemistry, Hässle Cardiovascular Research Laboratories, Mölndal, Sweden.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):140-5. doi: 10.1007/BF00169240.
beta-Adrenoceptor agonists inhibit contractile activity in isolated colon strips. In order to demonstrate that beta-adrenoceptors are located at different functional levels within the colon wall, increasing concentrations of muscarinic agonists were used to interact functionally with the beta-adrenoceptor-mediated inhibition of spontaneous colon activity. The effects of the full agonists isoprenaline and terbutaline and of the partial agonist prenalterol were functionally antagonized by carbachol (0.03 and 0.3 mumol/l) and bethanechol (1.3 and 30 mumol/l). This functional antagonism was parallelled by an increase in baseline tension and spontaneous contractile activity of the isolated colon strip. At lower concentrations of carbachol (0.003 and 0.01 mumol/l) or bethanechol (0.03 and 0.3 mumol/l) no effect on the contractile status of the smooth muscle or on the pD2-values of the full agonists was seen. However, at these lower concentrations of muscarinic agonists a marked decrease in the maximal inhibitory response to the partial beta-adrenoceptor agonist prenalterol was demonstrated. The inhibitory response to prenalterol showed a biphasic concentration-response curve. The muscarinic antagonist atropine produced an increase in the maximal response of the high potency component of the concentration-response curve for prenalterol and an increase in the sensitivity to isoprenaline. These results demonstrate the presence of a high cholinergic tone in the colon preparation of a magnitude that clearly reduces the sensitivity to beta-adrenoceptor agonists. The different responses to full and partial beta-adrenoceptor agonists in the presence of increasing concentrations of muscarinic agonists may indicate that beta-adrenoceptors are located on two different functional units within the colon wall.
β-肾上腺素能受体激动剂可抑制离体结肠条的收缩活性。为了证明β-肾上腺素能受体位于结肠壁内不同的功能水平,使用浓度递增的毒蕈碱激动剂与β-肾上腺素能受体介导的自发性结肠活动抑制进行功能性相互作用。完全激动剂异丙肾上腺素和特布他林以及部分激动剂普瑞特罗的作用在功能上被卡巴胆碱(0.03和0.3μmol/L)和氨甲酰甲胆碱(1.3和30μmol/L)所拮抗。这种功能性拮抗伴随着离体结肠条基线张力和自发性收缩活性的增加。在较低浓度的卡巴胆碱(0.003和0.01μmol/L)或氨甲酰甲胆碱(0.03和0.3μmol/L)时,未观察到对平滑肌收缩状态或完全激动剂的pD2值有影响。然而,在这些较低浓度的毒蕈碱激动剂下,对部分β-肾上腺素能受体激动剂普瑞特罗的最大抑制反应明显降低。对普瑞特罗的抑制反应呈现双相浓度-反应曲线。毒蕈碱拮抗剂阿托品使普瑞特罗浓度-反应曲线高效能成分的最大反应增加,并增加了对异丙肾上腺素的敏感性。这些结果表明,结肠制剂中存在较高的胆碱能张力,其程度明显降低了对β-肾上腺素能受体激动剂的敏感性。在浓度递增的毒蕈碱激动剂存在下,对完全和部分β-肾上腺素能受体激动剂的不同反应可能表明β-肾上腺素能受体位于结肠壁内两个不同的功能单位上。